NASPGHAN Clinical Report on the Evaluation and Treatment of Pediatric Patients with Internal Penetrating Crohn Disease: Intraabdominal Abscess with and Without Fistula
The natural history of pediatric Crohn disease (CD) remains unpredictable, although some trends are observed that differentiate children from adults. Pediatric CD often presents with more severe disease and more frequent need for immunosuppressive therapy (1). Growth failure, present in 15% to 20% of patients, is a unique characteristic of pediatric CD not seen in adult-onset CD (2). Colonic disease distribution is common in patients younger than 10 years (1). The need for surgical intervention also varies, with 1 study reporting the actuarial risk of having undergone an extensive intestinal resection being 48.6% ± 5% in a childhood-onset group versus 14.6% ± 2% in the adult-onset group (P < 0.001) (1). More recently, long-term follow-up of patients enrolled in pediatric registries shows a cumulative surgical rate of 14% to 17% at 5 years and 28% at 10 years (3,4).
Marshalleck, F. E.,
Saeed, S. A.,
Splawski, S. A.,
Linden, J. B.,
& Weston, B. F.
(2013). NASPGHAN Clinical Report on the Evaluation and Treatment of Pediatric Patients with Internal Penetrating Crohn Disease: Intraabdominal Abscess with and Without Fistula. Journal of Pediatric Gastroenterology and Nutrition, 57 (3), 394-400.